[1]
Hasan, I. 2022. Tenofovir Alafenamide (TAF) as Long-Term Therapy for Chronic Hepatitis B: Is It the Best Choice?. The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy. 23, 3 (Dec. 2022), 173. DOI:https://doi.org/10.24871/2332022173.